Moderna Inc at Cowen HealthCare Conference Transcript
© -
We'll be making a few forward-looking statements, so you can look at our forward-looking statements on our website or on the SEC website. So as many of you know, we started the company 9 years ago. We believe that messenger RNA could be a new class of medicines. We're very excited with that because we thought if mRNA could be a safe medicine in human, we could have a very large product opportunity making human proteins in humans, we'll be making antibodies and making vital protein in humans that are making vaccines. We thought because mRNA is an information where I feel that this will be a platform, meaning an incredible ability to learn from one product to be other and the ability to have an increased probability of technical success, take the drugs from preclinical models to the clinic to BLA.
Well, so forth, because mRNA is an information molecule, I think, we invested in manufacturing processes, in robotics, in IT early, we should be able to go very fast. And we saw that because mRNA is made in water, it's a cell-free
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |